Header Logo

Connection

MICHELE YORK to Amyloid beta-Peptides

Back to Details
This is a "connection" page, showing publications MICHELE YORK has written about Amyloid beta-Peptides.
MICHELE YORK
Connection Strength
0.052
Amyloid beta-Peptides
  1. Cognitive reserve predicts baseline tau burden in the U.S. POINTER trial imaging cohort. Alzheimers Dement. 2025 11; 21(11):e70892.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.